193 related articles for article (PubMed ID: 13864646)
1. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S
J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646
[No Abstract] [Full Text] [Related]
2. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.
FLETCHER AP; ALKJAERSIG N; SHERRY S
J Clin Invest; 1962 Apr; 41(4):896-916. PubMed ID: 13893560
[No Abstract] [Full Text] [Related]
3. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.
ALKJAERSIG N; FLETCHER AP; SHERRY S
J Clin Invest; 1962 Apr; 41(4):917-34. PubMed ID: 13860492
[No Abstract] [Full Text] [Related]
4. [Fibrinolysis and fibrinolytic hemorrhagic diatheses].
FAVRE-GILLY J; POTTON F
J Med Lyon; 1952 Oct; 33(786):869-81. PubMed ID: 13023221
[No Abstract] [Full Text] [Related]
5. Fibrinogen and fibrin degradation products in hemolytic transfusion reactions.
Sack ES; Nefa OM
Transfusion; 1970; 10(6):317-21. PubMed ID: 5490098
[No Abstract] [Full Text] [Related]
6. Fibrinogen Marburg a new genetic variant of fibrinogen.
Fuchs G; Egbring R; Havemann K
Blut; 1977 Feb; 34(2):107-18. PubMed ID: 836966
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinolysis as a cause of hemorrhagic diathesis].
ASTRUP T; ALBRECHTSEN OK
Ugeskr Laeger; 1956 Apr; 118(15):403-8. PubMed ID: 13352470
[No Abstract] [Full Text] [Related]
8. Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis.
Görög A; Németh K; Szabó L; Mayer B; Silló P; Kolev K; Kárpáti S
J Dermatol Sci; 2016 Oct; 84(1):17-23. PubMed ID: 27440075
[TBL] [Abstract][Full Text] [Related]
9. CURRENT STATUS OF THROMBOLYTIC THERAPY.
SHERRY S
Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
[No Abstract] [Full Text] [Related]
10. [Hemorrhagic diathesis due to coagulative and fibrinolytic abnormalities].
Terao A
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):209-13. PubMed ID: 11031932
[No Abstract] [Full Text] [Related]
11. [Disorders of coagulation/fibrinolysis and bleeding tendency].
Endo T; Amemiya N; Kume S
Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
[TBL] [Abstract][Full Text] [Related]
12. A haemorrhagic disorder in pregnancy due to an "anticoagulant" preventing the conversion of fibrinogen to fibrin.
BAKER SJ; JACOB E
J Clin Pathol; 1960 May; 13(3):214-9. PubMed ID: 13796035
[TBL] [Abstract][Full Text] [Related]
13. Meningiomas and hemorrhagic diathesis.
Oka K; Tsuda H; Kamikaseda K; Nakamura R; Fukui M; Nouzuka Y; Sueishi K
J Neurosurg; 1988 Sep; 69(3):356-60. PubMed ID: 3404232
[TBL] [Abstract][Full Text] [Related]
14. [HEMORRHAGIC DIATHESIS CAUSED BY HIGH FIBRINOLYTIC ACTIVITY OF THE BLOOD].
MAZURIN AV; PLAKHUTA TG
Vopr Okhr Materin Det; 1965 Feb; 10():54-8. PubMed ID: 14259090
[No Abstract] [Full Text] [Related]
15. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS].
OPPELT HG; BECK L
Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686
[No Abstract] [Full Text] [Related]
16. Pathological fibrinolysis secondary to pseudoaneurysms.
Babu SC; Bole P; Sharma P; Purdy R; Clauss RH
Surgery; 1980 Feb; 87(2):202-4. PubMed ID: 7355390
[TBL] [Abstract][Full Text] [Related]
17. [Coagulation disorders without hemorrhagic diathesis due to delayed aggregration of fibrin molecules].
von Felten A; Duckert F; Frick P
Schweiz Med Wochenschr; 1965 Oct; 95(43):1453-6. PubMed ID: 5880932
[No Abstract] [Full Text] [Related]
18. Disorders of Fibrinogen and Fibrinolysis.
May JE; Wolberg AS; Lim MY
Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
[TBL] [Abstract][Full Text] [Related]
19. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
Enev N
Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
[No Abstract] [Full Text] [Related]
20. Coagulation defects in obstetric shock: meconium embolism and heparin; fibrin embolism and defibrination.
SCHNEIDER CL
Am J Obstet Gynecol; 1955 Apr; 69(4):758-75. PubMed ID: 14361493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
